Literatur
-
1
Adams K E, Cohen M H, Eisenberg D. et al .
Ethical considerations of complementary amd alternative medical therapies in conventional medical settings.
Ann Intern Med.
2002;
137
660-664
-
2 Aronson J K, White N J. Principles of clinical pharmacology and drug Therapy. Oxford University Press. Oxford In: Oxford Textbook of Medicine, 3. Aufl., hrg. v. D J Weatherall, J G G Ledingham, D A Warrell 1996: 1259
-
3
Barsky A J, Saintfort R, Rogers M P. et al .
Nonspecific medication side effects and the nocebo phenomen.
JAMA.
2002;
287
622-627
-
4
Brody H.
The lie that heals: the ethics of giving placebos.
Ann Intern Med.
1982;
97
112-118
-
5 Brody H. The Healer’s power. Yale University Press. New Haven 1992: 34
-
6
Chan A T, Giovannucci E L, Schernhammer E S. et al .
A prospective study of aspirin use and the risk for colorectal adenoma.
Ann Intern Med.
2004;
140
157-166
-
7
Cohen M H, Eisenberg D M.
Potential physician malpractice liability associated with complementary and integrative medical therapies.
Ann Intern Med.
2002;
136
596-603
-
8
De Saintonge D MC, Herxheimer A.
Harnessing placebo effects in health care.
Lancet.
1994;
344
995-998
-
9
Di Blasi Z, Harkness E, Ernst E. et al .
Influence of context effects on health outcomes: a systematic review.
Lancet.
2001;
357
757-762
-
10
Emanuel E J, Mitter F G.
The ethics of placebo-controlled trials - a middle ground.
N Engl J Med.
2001;
345
915-919
-
11 Engelhardt K. Placebos, alternative Medizin und die Arzt-Patient Beziehung. Marseille, München In: Erweiterte Schulmedizin, Bd 2, hrg. v. R Saller und H Feiereis 1995: 199
-
12
Ernst E, Resch K L.
The science and art of the placebo-effect: Current therapeutics. Update 15. Nov.
1994;
619-622
-
13
Ernst E, Herxheimer A.
The power of placebo.
BMJ.
1996;
313
1569-1570
-
14
Ernst E, Cohen M H.
informed consent in complementary and alternative medicine.
Arch Intern Med.
2001;
161
2288-2292
-
15
Escher M, Desmeules J, Giostra E. et al .
Hepatitis associated with Kava, a herbal remedy for anxiety.
BMJ.
2001;
322
139
-
16
Fahrländer H, Truog P.
Placebowirkung und Alternativmedizin.
Schweiz Med Wochenschr.
1990;
120
581-588
-
17
Geisler L S.
Patientenautonomie - eine kritische Begriffsbestimmung.
Dtsch Med Wochenschr.
2004;
129
453-456
-
18
Goldman P.
Herbal medicines today and the roots of modern pharmacology.
Ann Intern Med.
2001;
135
594-600
-
19
Habermann E.
Vergiftet ohne Gift. Glauben und Angst in der Toxikologie.
Skeptiker.
1995;
8
92-100
-
20
Habermann E.
Wappen schlägt Zahl. Die biologische Grundlage des Placebo und Nocebo.
Futura.
1996;
3
178-188
-
21
Hill J.
Placebos in clinical care: for whose pleasure?.
Lancet.
2003;
362
254
-
22
Kaptchuk T J.
The placebo effect in alternative medicine: can the performance of a healing ritual have clinical significance?.
Ann Intern Med.
2002;
136
817-825
-
23
Klein K B.
Controlled treatment trials in the irritable bowel syndrome: a critique.
Gastroenterology.
1988;
95
32-41
-
24
Köbberling J.
Die Wissenschaft verpflichtet.
Internist.
1997;
38
M154-M161
-
25
Lasagna L, Mosteller F, von Felsinger J M, Beecher H K.
A study of the placebo response.
Am J Med.
1954;
16
770-779
-
26
Lynöe N, Sandlund M, Dahlquist G. et al .
Informed consent: study of quality of information given to participants in a clinical trial.
BMJ.
1991;
303
610-613
-
27
Mason S, Tovey P, Long A F.
Evaluating complementary medicine: methodological challenges of randomised controlled trials.
BMJ.
2002;
325
832-834
-
28
Miller F G, Emanuel E J, Rosenstein D L. et al .
Ethical issues concerning research in complementary and alternative medicine.
JAMA.
2004;
291
599-604
-
29
Parker M, Carver J R, Rodeheffer R J. et al .
Effect of oral milrinone on mortality in severe chronic heart failure.
N Engl J Med.
1991;
325
1468-1475
-
30
Preston R A, Materson B J, Reda D J. et al .
Placebo-associated blood pressure response and adverse effects in the treatment of hypertension.
Arch Intern Med.
2000;
160
1449-1454
-
31
Raspe H.
Ethische Implikationen der Evidenz-basierten Medizin.
Dtsch Med Wochenschr.
2002;
127
1769-1773
-
32
Sandler R S.
Aspirin Prevention of colorectal cacer: more or less?.
Ann Intern Med.
2004;
140
224-225
-
33
Shane E, Addesso V, Namerow P B. et al .
Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation.
N Engl J Med.
2004;
350
767-776
-
34
Solomon P R, Adams F, Silver A. et al .
Ginkgo for memory enhancement: a randomized controlled trial.
JAMA.
2002;
288
835-840
-
35 Spiro H M. Doctors, Patients, and Placebos. Yale University Press, New Haven 1986 86: 239
-
36
Tattersall M HN.
Examining informed consent to cancer clinical trials.
Lancet.
2001;
358
1742-1743
-
37
Thomas K B.
The placebo in general practice.
Lancet.
1994;
344
1066-1067
-
38
Turner J A, Deyo R A, Loeser J D. et al .
The importance of placebo effects in pain treatment and research.
JAMA.
1994;
271
1609-1614
-
39
Van Weel C.
Examination of context of medicine.
Lancet.
2001;
357
733-734
Prof. Dr. med. Karlheinz Engelhardt
Jaegerallee 7
24159 Kiel
